News | February 07, 2011

KLAS Names Elekta’s Oncology Information System as Category Leader

February 7, 2011 – Elekta's vendor-neutral Mosaiq Oncology Information System (OIS) has earned the No. 1 ranking in the oncology software category from KLAS, an independent research firm.

The 2010 Top 20 Best in KLAS Awards: Software and Professional Services report provides a summary of the KLAS performance ratings gathered over the past 12 months for healthcare IT software and service vendors in 113 market segments. Each segment includes a listing of vendor products ranked according to their KLAS performance scores, which have been compiled from the feedback from 17,667 healthcare providers.

"The unique ability to streamline clinical operations and enable clinics to integrate vendor-neutral hardware and software has always been a valued cornerstone of the Mosaiq OIS," says Todd Powell, executive vice president, Elekta Software. "We're honored to have Mosaiq recognized as being such a valuable contributor to patient care."

The system streamlines radiation oncology and medical oncology workflow from the first encounter, through diagnosis and staging, planning, treatment and long-term follow-up. At the heart of the system is the image-enabled electronic medical record (EMR) by which healthcare professionals communicate information about their patients throughout the continuum of cancer care.

For more information: www.elekta.com

Related Content

Members of Congress from both sides of the aisle issued a series of oversight letters to the Centers for Medicare and Medicaid Services (CMS) in recent months to urge the Agency to adjust its proposed radiation oncology advanced alternative payment model (RO Model)

Image by whitfieldink from Pixabay

News | Radiation Oncology | November 13, 2019
November 13, 2019 — Members of Congress from both sides of the aisle issued a series of oversight letters to the...
Bladder Abdomen Pelvis image with DLCExpert
News | Artificial Intelligence | November 07, 2019
November 7, 2019 — Mirada Medical, a global leader in...
Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...
MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment
News | Treatment Planning | October 18, 2019
The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an...
Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Feature | Prostate Cancer | October 16, 2019 | By Jeff Zagoudis
Radiation therapy is an important tool in the clinician’s armamentarium for treatment of localized, early-stage prost
Videos | Radiation Oncology | October 11, 2019
Lorraine Drapek, DNP, nurse practitioner, radiation oncology, GI service,...